RadNet Inc
SWB:PQIA
Relative Value
The Relative Value of one
PQIA
stock under the Base Case scenario is
51.6
EUR.
Compared to the current market price of 59.5 EUR,
RadNet Inc
is
Overvalued by 13%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PQIA Competitors Multiples
RadNet Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
RadNet Inc
SWB:PQIA
|
5.4B EUR | 2.7 | -423.5 | 31.5 | 72.7 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.3B USD | 0.2 | 55.1 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.2B EUR | 0.3 | 12.5 | 8 | 10.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.6B USD | 0.3 | 12.1 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
29.3B EUR | 1.3 | 25.5 | 11.1 | 16.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24.2B EUR | 1.2 | 33.6 | 10.6 | 22.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.3B USD | 1.7 | 26.5 | 12.7 | 18.4 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.2B USD | 2 | 22.5 | 12.4 | 16.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 0.6 | 16.4 | 6.5 | 13.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.9B USD | 14.3 | -32.4 | -34.2 | -31.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 13.9 | 7.3 | 9.9 |